[1]
Oliveira, A.G. de and Silveira, D. 2020. APPROACH TO CLINICAL TRIALS AUTHORIZED IN BRAZIL BY THE NATIONAL HEALTH SURVEILLANCE AGENCY UNTIL JUNE 30, 2020. Infarma - Pharmaceutical Sciences. 32, 2 (Jul. 2020), 107–108. DOI:https://doi.org/10.14450/2318-9312.v32.e2.a2020.pp107-108.